CURA Stock Overview
Operates a cannabis operator in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Curaleaf Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.77 |
| 52 Week High | CA$8.73 |
| 52 Week Low | CA$2.27 |
| Beta | 1.49 |
| 11 Month Change | -43.35% |
| 3 Month Change | -36.32% |
| 1 Year Change | -42.65% |
| 33 Year Change | -78.05% |
| 5 Year Change | -65.24% |
| Change since IPO | -67.68% |
Recent News & Updates
Recent updates
Investors Give Curaleaf Holdings, Inc. (TSE:CURA) Shares A 27% Hiding
Nov 09
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Shareholder Returns
| CURA | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -10.6% | -6.1% | 0.7% |
| 1Y | -42.7% | -22.3% | 21.7% |
Return vs Industry: CURA underperformed the Canadian Pharmaceuticals industry which returned -22.3% over the past year.
Return vs Market: CURA underperformed the Canadian Market which returned 21.7% over the past year.
Price Volatility
| CURA volatility | |
|---|---|
| CURA Average Weekly Movement | 15.1% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CURA's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: CURA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 5,650 | Boris Jordan | www.curaleaf.com |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Curaleaf Holdings, Inc. Fundamentals Summary
| CURA fundamental statistics | |
|---|---|
| Market cap | CA$2.21b |
| Earnings (TTM) | -CA$288.16m |
| Revenue (TTM) | CA$1.89b |
1.1x
P/S Ratio-7.2x
P/E RatioIs CURA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CURA income statement (TTM) | |
|---|---|
| Revenue | US$1.36b |
| Cost of Revenue | US$718.94m |
| Gross Profit | US$638.08m |
| Other Expenses | US$844.47m |
| Earnings | -US$206.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.28 |
| Gross Margin | 47.02% |
| Net Profit Margin | -15.21% |
| Debt/Equity Ratio | 51.4% |
How did CURA perform over the long term?
See historical performance and comparison